Ultra Clean to Participate in the Dougherty & Company 2016 Institutional Investor Conference
Get Alerts UCTT Hot Sheet
Join SI Premium – FREE
HAYWARD, Calif., Sept. 20, 2016 /PRNewswire/ -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT), a leading developer and supplier of critical systems and subsystems for the semiconductor capital equipment, flat panel, medical, energy and research industries, today announced Jim Scholhamer, Chief Executive Officer and Sheri Brumm, Senior Vice President and Chief Financial Officer will participate in the Dougherty & Company 2016 Institutional Investor Conference being held Wednesday, September 28, 2016 at the Millennium Hotel in Minneapolis, MN.
About Ultra Clean Holdings, Inc. Ultra Clean Holdings, Inc. is a leading developer and supplier of critical systems and subsystems for the semiconductor capital equipment, flat panel, medical, energy and research industries. Ultra Clean offers its customers an integrated outsourced solution for gas delivery systems and other subassemblies, improved design-to-delivery cycle times, component neutral design and manufacturing and component testing capabilities. Ultra Clean's customers are primarily original equipment manufacturers for the semiconductor capital equipment, flat panel, medical, energy and research industries. Ultra Clean is headquartered in Hayward, California. Additional information is available at www.uct.com.
Contact:Annie Leschin(415) 775-1788[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ultra-clean-to-participate-in-the-dougherty--company-2016-institutional-investor-conference-300331225.html
SOURCE Ultra Clean Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackwell 3D Launches New Website, Eyes Project Development
- Futu Holdings Limited Announces Filing of Its Annual Report on Form 20-F for Fiscal Year 2023
- ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!